Cargando…
WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients
Platinum-based chemotherapy toxicity is always one of the serious problems from which lung cancer patients suffer. The genetic polymorphism of WISP1 was revealed to be associated with susceptibility and platinum-based chemotherapy response in our previous studies. In this study, we aimed to investig...
Autores principales: | Chen, Juan, Yin, Jiye, Li, Xiangping, Wang, Ying, Zheng, Yi, Qian, Chenyue, Xiao, Ling, Zou, Ting, Wang, Zhan, Liu, Junyan, Zhang, Wei, Zhou, Honghao, Liu, Zhaoqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264209/ https://www.ncbi.nlm.nih.gov/pubmed/25405734 http://dx.doi.org/10.3390/ijms151121011 |
Ejemplares similares
-
The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
por: He, Jia, et al.
Publicado: (2021) -
Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysis
por: Chen, Juan, et al.
Publicado: (2016) -
A perspective profile of ADCY1 in cAMP signaling with drug-resistance in lung cancer
por: Zou, Ting, et al.
Publicado: (2019) -
Genome-wide analysis identify novel germline genetic variations in ADCY1 influencing platinum-based chemotherapy response in non-small cell lung cancer
por: Mao, Chenxue, et al.
Publicado: (2022) -
A Functional 5'-UTR Polymorphism of MYC Contributes to Nasopharyngeal Carcinoma Susceptibility and Chemoradiotherapy Induced Toxicities
por: Guo, Zhen, et al.
Publicado: (2019)